• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cirtec Medical Announces Appointment of New Chief Executive Officer

    8/28/25 12:59:55 PM ET
    $KRMD
    Medical/Dental Instruments
    Health Care
    Get the next $KRMD alert in real time by email

    BROOKLYN PARK, Minn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a leading strategic outsourcing partner for complex minimally invasive, active implantable devices and precision components, is pleased to announce the appointment of Shar Matin as Chief Executive Officer, effective September 2, 2025.

    Shar brings more than 25 years of global leadership experience in the medical technology sector, with a proven track record of scaling businesses, driving innovation, and building strong customer partnerships. He most recently served as CEO of Cordis, where he led the successful transformation from a division of Cardinal Health to one of the world's largest pure-play cardiovascular companies, including spearheading the acquisition of MedAlliance's drug-eluting balloon technology. Prior to Cordis, Shar held senior executive roles at ViewRay Technologies, Spectranetics (acquired by Royal Philips), Boston Scientific, and Guidant (acquired by Boston Scientific and Abbott Laboratories). Through these roles, he consistently delivered growth through new product innovation, strategic acquisitions, and global expansion. Shar started his career as a process and manufacturing engineer. He holds an MBA from Harvard Business School and a Bachelor of Science in Mechanical Engineering from the University of California, Berkeley. Shar also serves on the Board of Directors for Koru Medical Systems (NASDAQ:KRMD).

    "Shar is an experienced leader with a demonstrated ability to accelerate growth, strengthen customer partnerships, and drive innovation," said Rich Relyea, Cirtec Board member and 3i Private Equity Partner. "On behalf of the Board, we are excited to welcome him to Cirtec and are confident he will build on the company's strong foundation and help shape its next chapter of success."

    Reflecting on his appointment, Shar shared: "Cirtec has tremendous momentum, and I am humbled and privileged to lead the company into its next phase of growth while building on the incredible foundation already in place. Together with our teammates and as a trusted partner to our customers, I look forward to fulfilling our mission of bringing life-changing medical technologies to market for the betterment of patient care."

    The Cirtec Board of Directors also expressed its gratitude to Brian Highley for his leadership of Cirtec over the past decade. "Brian transformed Cirtec over the course of 11 years into an industry-leading CDMO with remarkable growth and expansion. His vision and commitment have been instrumental in establishing Cirtec as a trusted partner to some of the world's most innovative medical technology companies, and we thank Brian for all his contributions to building Cirtec into the leader that it is today."

    The Board also thanks Ed Philbin, who served as Interim CEO over the past several months, for his leadership during the transition period. His dedication and support have been key in continuing Cirtec's momentum and delivering a seamless handover to new leadership.

    About Cirtec Medical

    Cirtec Medical is a global leader in design, development, and manufacturing of complex Class II and III medical devices, specializing in active implant systems, interventional devices, and precision components. Since 1987, Cirtec Medical has built extensive in-house capabilities that enable the company to serve as a single-source partner and collaborate with customers to transform their technology into innovative medical devices across a wide array of therapies, including cardiology, neurology, orthopedics and other minimally invasive device applications. Cirtec Medical's deep expertise in precision component design and manufacturing supports every stage of the product lifecycle, ensuring uncompromising quality and performance. With 11 global facilities and a vertically integrated approach, Cirtec Medical aims to expedite time to market, reduce risk, and accelerate revenue generation for our partners. Learn more at CirtecMed.com.

    For Media Inquiries

    Abby Kupka

    Sr. Manager, Marketing

    Cirtec Medical

    (763) 235-8835



    Get the next $KRMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $KRMD

    DatePrice TargetRatingAnalyst
    2/14/2025$4.50Overweight → Neutral
    Piper Sandler
    7/25/2024$4.00Buy
    B. Riley Securities
    9/7/2023$4.00Buy
    Lake Street
    9/7/2023$4.50Buy
    B. Riley Securities
    11/10/2022$3.00 → $4.00Hold → Buy
    Canaccord Genuity
    11/10/2022$3.00 → $3.50Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $KRMD
    SEC Filings

    View All

    KORU Medical Systems Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - KORU Medical Systems, Inc. (0000704440) (Filer)

    3/13/26 9:44:41 PM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    SEC Form 10-K filed by KORU Medical Systems Inc.

    10-K - KORU Medical Systems, Inc. (0000704440) (Filer)

    3/12/26 4:09:20 PM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    KORU Medical Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - KORU Medical Systems, Inc. (0000704440) (Filer)

    3/12/26 4:05:55 PM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    $KRMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Kalbermatten Adam R

    4 - KORU Medical Systems, Inc. (0000704440) (Issuer)

    3/18/26 4:52:45 PM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Pazdan Christopher

    4 - KORU Medical Systems, Inc. (0000704440) (Issuer)

    3/18/26 4:47:47 PM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Adams Thomas Edward

    4 - KORU Medical Systems, Inc. (0000704440) (Issuer)

    3/18/26 4:45:22 PM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    $KRMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility

    KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that its Freedom60® Infusion Pump, including adapter for use with 50 mL prefilled syringes, has achieved certification under the European Union Medical Devices Regulation (EU MDR 2017/745), enabling commercialization across the European Union. The Freedom60 Infusion Pump is designed to support dosing with 50 ml prefilled syringes, while the FreedomEDGE® Infusion System provides a compatible option for 20 mL prefilled sy

    3/13/26 8:00:00 AM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    KORU Medical Systems Announces CEO Transition

    Linda Tharby to Retire after Five Years of Transformational Leadership; Adam Kalbermatten Appointed CEO, effective July 1, 2026 KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that following five years of service to the Company, Linda Tharby, President and Chief Executive Officer, will retire effective June 30, 2026. The Board of Directors has appointed Adam Kalbermatten, currently Chief Commercial Officer, as President and Chief Executive Officer, effective March 15

    3/12/26 4:08:00 PM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance

    KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025. The Company also initiated guidance for the full year 2026. Recent Highlights Fourth quarter 2025 net revenues grew 23% to $10.9 million; Full year 2025 net revenues grew 22% to $41.1 million Full year 2025 gross profit grew 20% to $25.6 million with gross margin of 62.3% Full year 2025 net loss of ($2.6) million, a 57% improvement o

    3/12/26 4:05:00 PM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    $KRMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Manko Joseph M. Jr. bought $349,999 worth of shares (145,833 units at $2.40) and sold $349,999 worth of shares (145,833 units at $2.40) (SEC Form 4)

    4 - KORU Medical Systems, Inc. (0000704440) (Issuer)

    12/15/23 4:05:24 PM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    $KRMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    KORU Medical Systems downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded KORU Medical Systems from Overweight to Neutral and set a new price target of $4.50

    2/14/25 8:08:51 AM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    B. Riley Securities resumed coverage on KORU Medical Systems with a new price target

    B. Riley Securities resumed coverage of KORU Medical Systems with a rating of Buy and set a new price target of $4.00

    7/25/24 8:28:49 AM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    Lake Street initiated coverage on KORU Medical Systems with a new price target

    Lake Street initiated coverage of KORU Medical Systems with a rating of Buy and set a new price target of $4.00

    9/7/23 9:12:10 AM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    $KRMD
    Leadership Updates

    Live Leadership Updates

    View All

    KORU Medical Systems Announces CEO Transition

    Linda Tharby to Retire after Five Years of Transformational Leadership; Adam Kalbermatten Appointed CEO, effective July 1, 2026 KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that following five years of service to the Company, Linda Tharby, President and Chief Executive Officer, will retire effective June 30, 2026. The Board of Directors has appointed Adam Kalbermatten, currently Chief Commercial Officer, as President and Chief Executive Officer, effective March 15

    3/12/26 4:08:00 PM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer

    KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on developing, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced the appointment of Eric Schiller as Chief Technology Officer, effective December 29, 2025. Eric joins KORU Medical with more than 25 years of leadership experience across research & development, device engineering, drug–device combination product development, supply chain strategy, and end-to-end product lifecycle management. As Chief Technology Officer, Eric will lead KORU's product development and innovation pipeline and he

    12/16/25 4:05:00 PM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    Cirtec Medical Announces Appointment of New Chief Executive Officer

    BROOKLYN PARK, Minn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a leading strategic outsourcing partner for complex minimally invasive, active implantable devices and precision components, is pleased to announce the appointment of Shar Matin as Chief Executive Officer, effective September 2, 2025. Shar brings more than 25 years of global leadership experience in the medical technology sector, with a proven track record of scaling businesses, driving innovation, and building strong customer partnerships. He most recently served as CEO of Cordis, where he led the successful transformation from a division of Cardinal Health to one of the world's largest pure-play cardiovascular compa

    8/28/25 12:59:55 PM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    $KRMD
    Financials

    Live finance-specific insights

    View All

    KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance

    KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025. The Company also initiated guidance for the full year 2026. Recent Highlights Fourth quarter 2025 net revenues grew 23% to $10.9 million; Full year 2025 net revenues grew 22% to $41.1 million Full year 2025 gross profit grew 20% to $25.6 million with gross margin of 62.3% Full year 2025 net loss of ($2.6) million, a 57% improvement o

    3/12/26 4:05:00 PM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

    KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report fourth quarter and full year 2025 financial results on Thursday, March 12, 2026. KORU Medical's management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Conference Call and Webcast Details The conference call can be accessed by dialing (877)-407-0784 for participants in the U.S. or Canada and (201)-689-8560 for

    2/26/26 4:05:00 PM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance

    KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the third quarter ended September 30, 2025. Recent Highlights • Third quarter 2025 net revenues of $10.4 million, a 27% increase over the prior year period • Core business (Domestic and International) net revenues of $9.8 million, a 30% increase over the prior year period • Announced two new Pharma Services and Clinical Trials (PST) collaborations expanding opportunity to reach new p

    11/12/25 4:05:00 PM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    $KRMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by KORU Medical Systems Inc.

    SC 13G/A - KORU Medical Systems, Inc. (0000704440) (Subject)

    11/14/24 7:00:30 AM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by KORU Medical Systems Inc.

    SC 13G/A - KORU Medical Systems, Inc. (0000704440) (Subject)

    11/13/24 4:23:54 PM ET
    $KRMD
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by KORU Medical Systems Inc.

    SC 13G - KORU Medical Systems, Inc. (0000704440) (Subject)

    5/23/24 7:00:28 AM ET
    $KRMD
    Medical/Dental Instruments
    Health Care